Merck Frosst Canada & CompanyŐs mission is in the treatment and prevention of disease. Since its founding in Montreal by Charles E. Frosst at the turn of the last century, our company is a leader in pharmaceutical research, perfecting medications that alleviate suffering, improve and prolong the life of patients in Canada and worldwide.

Merck Frosst is firmly rooted in CanadaŐs history of scientific research. In 2000, Merck Frosst invested over 100 million dollars in research and development. This amount represents 11% of R & D expenditures for the entire pharmaceutical industry in Canada. This investment allows Merck Frosst to discover new medications for respiratory conditions such as asthma, and inflammatory conditions such as arthritis.

Merck FrosstŐs Department of Pharmaceutical R & D must transform the concept into reality by establishing the posology that will allow the medication go from testing to the patient.